MARKET

ZBH

ZBH

Zimmer Biomet
NYSE

Real-time Quotes | Nasdaq Last Sale

118.26
-1.13
-0.95%
Opening 13:02 05/25 EDT
OPEN
118.85
PREV CLOSE
119.39
HIGH
120.72
LOW
118.23
VOLUME
401.46K
TURNOVER
23.56M
52 WEEK HIGH
168.57
52 WEEK LOW
105.23
MARKET CAP
24.78B
P/E (TTM)
82.30
1D
5D
1M
3M
1Y
5Y
FDA Denies Approval For NeuroOne Medical's Evo sEEG Electrode For Extended Use
Benzinga · 05/17 16:06
Here's Why Investors Should Retain Zimmer Biomet (ZBH) Now
Investors are optimistic about Zimmer Biomet's (ZBH) better-than-expected revenues and robust performance across several geographies.
Zacks · 05/17 16:01
Zimmer Biomet declares $0.24 dividend
Zimmer Biomet (NYSE:ZBH) declares $0.24/share quarterly dividend, in line with previous. Forward yield 0.83% Payable July 29; for shareholders of record June 27; ex-div June 24. See ZBH Dividend Scorecard,
Seekingalpha · 05/17 11:14
Citigroup Adjusts Price Target on Zimmer Biomet Holdings to $125 From $135, Maintains Neutral Rating
MT Newswires · 05/17 10:35
Zimmer Biomet Debuts First-of-its-Kind Artificial Intelligence Capabilities for Omni™ Suite Intelligent Operating Room
Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today introduced the availability of new artificial intelligence¹ (AI) capabilities within Omni™ Suite, an intelligent operating room (OR) designed to optimize surgical w...
PR Newswire · 05/10 11:00
Akerna Announces Financial Results for First Quarter 2022
Software revenue up 71%, total revenue up 73% year-over-yearDENVER, May 09, 2022 (GLOBE NEWSWIRE) -- Akerna (Nasdaq: KERN), a leading enterprise software company and developer of one of the most comprehensive technology infrastructures, ecosystems, and com...
GlobeNewswire · 05/09 20:30
Are Investors Undervaluing Zimmer Biomet Holdings, Inc. (NYSE:ZBH) By 31%?
How far off is Zimmer Biomet Holdings, Inc. ( NYSE:ZBH ) from its intrinsic value? Using the most recent financial...
Simply Wall St. · 05/09 17:03
Akerna Corp. Reminds Stockholders of Upcoming Annual Meeting; Urges Stockholders to Vote FOR all Proposals
DENVER, May 09, 2022 (GLOBE NEWSWIRE) -- Akerna Corp. (Nasdaq: KERN), a leading enterprise software company and developer of one of the most comprehensive technology infrastructures, ecosystems, and compliance engines powering the global cannabis industry,...
GlobeNewswire · 05/09 13:01
More
No Data
Learn about the latest financial forecast of ZBH. Analyze the recent business situations of Zimmer Biomet through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 26 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

15.38%Strong Buy
15.38%Buy
57.69%Hold
11.54%Under-perform
0.00%Sell
Analyst Price Target
The average ZBH stock price target is 131.55 with a high estimate of 145.00 and a low estimate of 114.00.
High145.00
Average131.55
Low114.00
Current 118.26
EPS
Actual
Estimate
0.500.991.491.98
Q2 2021
Q3 2021
Q4 2021
Q1 2022
Q2 2022
Institutional Holdings
Institutions: 1.33K
Institutional Holdings: 217.30M
% Owned: 103.69%
Shares Outstanding: 209.58M
TypeInstitutionsShares
Increased
316
14.55M
New
130
3.88M
Decreased
327
13.17M
Sold Out
107
4.88M
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
-0.44%
Healthcare Equipment & Supplies
-1.13%
Key Executives
Chairman/President/Chief Executive Officer/Director
Bryan Hanson
Chief Financial Officer/Executive Vice President
Suketu Upadhyay
Corporate Executive
Wilfred Van Zuilen
Corporate Executive
Sang Yi
Chief Operating Officer
Ivan Tornos
Chief Human Resource Officer/Senior Vice President
Lori Winkler
Senior Vice President/General Counsel/Secretary
Chad Phipps
Senior Vice President/Executive Officer
Rachel Ellingson
Chief Accounting Officer/Vice President/Controller
Paul Stellato
Vice President - Finance
Derek Davis
Lead Director/Independent Director
Christopher Begley
Independent Director
Betsy Bernard
Independent Director
Michael Farrell
Independent Director
Robert Hagemann
Independent Director
Arthur Higgins
Independent Director
Maria Hilado
Independent Director
Syed Jafry
Independent Director
Sreelakshmi Kolli
Independent Director
Michael Michelson
No Data
No Data
About ZBH
Zimmer Biomet Holdings, Inc. is engaged in designing, manufacturing and marketing of orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; office-based technologies; spine, craniomaxillofacial and thoracic products; dental implants, and related surgical products. The Company's products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. The Company manages its operations through three geographic operating segments: the Americas and Global Businesses, consisting principally of the United States and other North, Central and South American markets; Europe, Middle East and Africa (EMEA), consisting principally of France, Germany, Italy, Spain and the United Kingdom, and Asia Pacific, consisting primarily of Japan, China, Australia, New Zealand, Korea, Taiwan, India, Thailand, Singapore, Hong Kong and Malaysia.

Webull offers kinds of Zimmer Biomet Holdings Inc stock information, including NYSE:ZBH real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ZBH stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading ZBH stock methods without spending real money on the virtual paper trading platform.